Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

NCT01709929 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
2287
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novo Nordisk A/S